EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Lung Cancer Treatment 1st Edition Brandon S West Donna R Stanley

Name: Lung Cancer Treatment 1st Edition Brandon S West Donna R Stanley
SKU: BELL-51369364
Price: 31.00 USD
Availability: InStock
Rating: 4 (86 reviews)

SKU: BELL-51369364

$ 31.00 ~~$ 45.00~~ (-31%)

4.0

86 reviews

Lung Cancer Treatment 1st Edition Brandon S West Donna R Stanley instant download after payment.

Publisher: Nova Science Publishers, Incorporated

File Extension: PDF

File size: 5.68 MB

Pages: 169

Author: Brandon S. West; Donna R. Stanley

ISBN: 9781620819197, 1620819198

Language: English

Year: 2011

Edition: 1

Product desciption

Lung Cancer Treatment 1st Edition Brandon S West Donna R Stanley by Brandon S. West; Donna R. Stanley 9781620819197, 1620819198 instant download after payment.

Lung cancer is one of the leading causes of death worldwide with the majority of patients suffering from advanced unresectable or metastatic non-small cell lung cancer. Despite the advances in palliative chemotherapy, the survival rate for patients with this advanced disease treated with chemotherapy remains poor. In this new book, the authors present topical research in the study of lung cancer treatments including epidermal growth factor tyrosine kinase inhibitors, in the management of advanced stage non-small cell lung cancer; lung cancer brachytherapy; volumetric modulated arc therapy and future individualized therapy for lung cancer in post-genomic era.